Lindsey Shapiro is a science writer for Multiple Sclerosis News Today with a PhD in neuroscience. She covers the latest news and information on a variety of multiple sclerosis topics.| Multiple Sclerosis News Today
Most nonactive SPMS patients who took foralumab nasal spray for at least six months saw a decrease in microglial activity in their brains.| Multiple Sclerosis News Today